Role of Cochrane Reviews in informing US private payers’ policies

@article{Singh2017RoleOC,
  title={Role of Cochrane Reviews in informing US private payers’ policies},
  author={Ambrish Singh and Salman Hussain and Abul Kalam Najmi},
  journal={Journal of Evidence‐Based Medicine},
  year={2017},
  volume={10},
  pages={293 - 331}
}
To assess the use of Cochrane Reviews to inform the medical policy documents of major US private payers. 
1 Citations
Consideration of sex and gender in Cochrane reviews of interventions for preventing healthcare-associated infections: a methodology study
TLDR
Lack of attention to sex and gender reduces the quality of Cochrane reviews, and their applicability for all people: women and men, boys and girls, and people of diverse gender identities. Expand

References

SHOWING 1-10 OF 14 REFERENCES
Can patients assess the quality of health care?
  • A. Coulter
  • Medicine
  • BMJ : British Medical Journal
  • 2006
TLDR
Patients' surveys should ask about real experiences of medical care, according to the Royal College of Surgeons. Expand
New evidence pyramid
TLDR
Another way of looking at the evidence-based medicine pyramid is suggested and it is explained how systematic reviews and meta-analyses are tools for consuming evidence—that is, appraising, synthesising and applying evidence. Expand
Cochrane reviews used more rigorous methods than non-Cochrane reviews: survey of systematic reviews in physiotherapy.
TLDR
The quality of systematic reviews in physiotherapy is improving, and the use of Cochrane Collaboration procedures appears to improve the methods and quality. Expand
Evidence based medicine: what it is and what it isn't
TLDR
As evidence based medicine continues to evolve and adapt, now is a useful time to refine the discussion of what it is andWhat it is not. Expand
Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review
TLDR
Industry supported reviews of drugs should be read with caution as they were less transparent, had few reservations about methodological limitations of the included trials, and had more favourable conclusions than the corresponding Cochrane reviews. Expand
Quality of Cochrane reviews: assessment of sample from 1998
TLDR
Too often, reviewers' conclusions over-rated the benefits of new interventions and readers of Cochrane reviews should remain cautious, especially regarding conclusions that favour new interventions. Expand
Biologics for rheumatoid arthritis: an overview of Cochrane reviews.
TLDR
Anakinra seemed less efficacious than etanercept, adalimumab and rituximab and etanerscept seemed to cause fewer withdrawals due to adverse events than ad alimumab, anakinra and infliximab, according to indirect comparisons. Expand
NHMRC Levels of Evidence and Grades for Recommendations for Developers of Clinical Practice Guidelines
  • Available at: https://www.nhmrc.gov.au/_files_nhmrc/ file/guidelines/developers/nhmrc_levels_grades_evidence_120423.pdf. Accessed on
  • 2017
Top ten private payers in value based care
  • Available at: https://www.wellcentive.com/blog/top-ten-private-payers-valuebased-care/. Accessed on
  • 2017
Census Bureau. Current Population Reports, pg 1 Health Insurance Coverage in the United States: 2015, U.S
  • Government Printing Office,
  • 2016
...
1
2
...